Antioxidant vitamins and coronary heart disease.

Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A (1993) 13.27

Vitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health (1998) 1.16

Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. Heart Fail Rev (2014) 0.91

Trace elements, heavy metals and vitamin levels in patients with coronary artery disease. Int J Med Sci (2011) 0.89

Antioxidant nutrients, atherosclerosis, and coronary heart disease. Br Heart J (1995) 0.88

Why are low-density lipoproteins atherogenic? West J Med (1994) 0.88

Vitamin E and the risk of coronary disease. N Engl J Med (1993) 0.77

Granulocyte colony-stimulating factor promotes atherosclerosis in high-fat diet rabbits. Int J Mol Sci (2013) 0.76

Evidence for a recommended dietary allowance for vitamin C from pharmacokinetics: a comment and analysis. Proc Natl Acad Sci U S A (1996) 0.76

Vitamin E and the risk of coronary disease. N Engl J Med (1993) 0.75

Dietary antioxidants, cancer, and atherosclerotic heart disease. West J Med (1994) 0.75

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37

Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39

Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest (1991) 6.50

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A (1984) 6.01

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest (1989) 5.75

Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A (1989) 5.65

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 4.56

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A (1981) 4.50

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A (1987) 4.10

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A (1987) 3.55

Serum cholesterol. Doing the right thing. Circulation (1993) 3.16

ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb (1994) 3.11

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A (1988) 2.83

Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis (1983) 2.48

Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb (1994) 2.47

A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem (1989) 2.45

Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest (1986) 2.38

Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest (1991) 2.35

Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis (1986) 2.32

Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1996) 2.32

Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci U S A (1983) 2.25

Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A (1990) 2.23

Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 2.11

Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J Biol Chem (1982) 2.06

Uptake and degradation of low density lipoprotein by swine arterial smoot muscle cells with inhibition of cholesterol biosynthesis. Biochim Biophys Acta (1976) 2.05

Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci U S A (1995) 1.95

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol (1997) 1.87

The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med (2000) 1.87

Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J Biol Chem (1985) 1.86

Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci (2001) 1.82

Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis (1987) 1.80

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79

The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med (1992) 1.77

Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem (1983) 1.77

Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res (1988) 1.76

The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med (2001) 1.75

Tissue sites of degradation of low density lipoprotein: application of a method for determining the fate of plasma proteins. Proc Natl Acad Sci U S A (1979) 1.75

Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 1.73

The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A (1995) 1.67

Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc Natl Acad Sci U S A (1987) 1.63

Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry (1999) 1.62

A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A (1989) 1.62

Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol (1992) 1.60

Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci U S A (1999) 1.58

Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts. J Clin Invest (1977) 1.58

Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis (1988) 1.57

Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest (1969) 1.56

Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J Clin Invest (1970) 1.56

Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 1.55

Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res (1987) 1.54

Radiolabeled sucrose covalently linked to protein. A device for quantifying degradation of plasma proteins catabolized by lysosomal mechanisms. J Biol Chem (1979) 1.54

The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem (2000) 1.54

Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest (1982) 1.53

Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem (1997) 1.53

A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A (1995) 1.49

Interactions of plasma lipoproteins with endothelial cells. Ann N Y Acad Sci (1982) 1.46

Lipoproteins and atherosclerosis. A look back and a look ahead. Arteriosclerosis (1983) 1.45

Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J (1998) 1.44

Very low density lipoprotein synthesis and secretion by cultured rat hepatocytes. J Biol Chem (1979) 1.44

High-quality filtration allows reuse of anesthesia breathing circuits resulting in cost savings and reduced medical waste. J Clin Anesth (1999) 1.43

A mechanism by which high-density lipoproteins may slow the atherogenic process. Lancet (1976) 1.41

Development of a Head Scanner for Proton CT. Nucl Instrum Methods Phys Res A (2012) 1.39

Purification and characterization of lipoprotein lipase from pig adipose tissue. J Biol Chem (1974) 1.39

Firms sleuth out transgenic foods. Nat Biotechnol (1997) 1.38

Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res (1991) 1.36

Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes (1982) 1.36

The effect of dietary fat on the turnover of cholic acid and on the composition of the biliary bile acids in man. J Clin Invest (1965) 1.36

Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci U S A (1990) 1.34

Tissue sites of degradation of native and reductively methylated [14C]sucrose-labeled low density lipoprotein in rats. Contribution of receptor-dependent and receptor-independent pathways. J Biol Chem (1982) 1.32

Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol (1998) 1.31

Activation and phosphorylation of purified adipose tissue hormone-sensitive lipase by cyclic AMP-dependent protein kinase. Biochim Biophys Acta (1971) 1.31

The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J Biol Chem (1983) 1.30

Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. J Clin Invest (1973) 1.30

Hormone-sensitive lipase in differentiated 3T3-L1 cells and its activation by cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1981) 1.29

Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J Clin Invest (1979) 1.29

Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res (2001) 1.29

Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1994) 1.29

Metabolism of homologous and heterologous lipoproteins by cultured rat and human skin fibroblasts. J Lipid Res (1981) 1.29

Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest (1993) 1.29

Effect of free fatty acid on the oxygen consumption of perfused rat heart. Am J Physiol (1966) 1.26

Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tumor necrosis factor-alpha and interleukin-1 beta. Arterioscler Thromb Vasc Biol (2000) 1.26

Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins. Am J Physiol (1980) 1.24

Binding, internalization, and degradation of low density lipoprotein by normal human fibroblasts and by fibroblasts from a case of homozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A (1976) 1.23

Sterol and bile acid excretion in man and the effects of dietary fat. J Clin Invest (1965) 1.23

Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. J Clin Invest (1969) 1.22

A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. J Lipid Res (1984) 1.22

Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet (1966) 1.20

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest (1993) 1.19

Fatty acid mobilization--mechanisms of regulation and metabolic consequences. Biochem Soc Symp (1963) 1.19

Tissue sites of catabolism of rat and human low density lipoproteins in rats. Biochim Biophys Acta (1982) 1.17

Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem (1995) 1.17

Family unit in a children's psychiatric hospital. Br Med J (1975) 1.15

Low density lipoprotein receptor deficiency in cultured hepatocytes of the WHHL rabbit. Further evidence of two pathways for catabolism of exogenous proteins. J Biol Chem (1981) 1.15

Influenza infection causing manic psychosis. Br J Psychiatry (1972) 1.15

Cholesterol esterase in rat adipose tissue and its activation by cyclic adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1975) 1.15

Lipoprotein lipase secretion by human monocytes and rabbit alveolar macrophages in culture. Proc Natl Acad Sci U S A (1982) 1.13

Refsum's disease--a recently characterized lipidosis involving the nervous system. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.13

Receptor-mediated catabolism of homologous low density lipoproteins in cultured pig hepatocytes. J Biol Chem (1981) 1.13

Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. Proc Natl Acad Sci U S A (1998) 1.13

In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. J Antimicrob Chemother (2006) 1.12

Arthroscopic electrothermal collagen shrinkage for symptomatic laxity of the scapholunate interosseous ligament. J Hand Surg Br (2005) 1.12

Periarteritis nodosa, Australia antigen and lymphatic leukemia. N Engl J Med (1972) 1.12